Connection

Giuseppe Curigliano to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Giuseppe Curigliano has written about Protein Kinase Inhibitors.
Giuseppe Curigliano
Connection Strength
0.581
Protein Kinase Inhibitors
  1. Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting. Curr Opin Oncol. 2017 Nov; 29(6):428-433.
    View in: PubMed
    Score: 0.341
  2. Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer. Eur J Cancer. 2019 09; 118:41-48.
    View in: PubMed
    Score: 0.096
  3. Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors. Cancer Treat Rev. 2019 Mar; 74:21-28.
    View in: PubMed
    Score: 0.093
  4. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin. 2020 11; 70(6):480-504.
    View in: PubMed
    Score: 0.026
  5. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. Br J Cancer. 2020 09; 123(5):694-697.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.